康德莱 (603987.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.2x

Market Cap

CNY 3.26B

MomentumView details →

1D Return

−0.27%

YTD Return

−11.98%

RSI (14)

52.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

8.2x

Market Cap

CNY 3.26B

RSI (14)

52.7

MomentumView details →

1D Return

−0.27%

YTD Return

−11.98%

ProfitabilityView details →

Gross Margin

32.95%

Net Margin

10.22%

EBITDA Margin

20.15%

ROE (TTM)

8.21%

ROA (TTM)

5.50%

Asset Turnover

0.54x

GrowthView details →

Revenue YoY

+2.11%

EPS YoY

+7.41%

FCF YoY

+47.35%

Revenue CAGR 3Y

−9.67%

EPS CAGR 3Y

−8.16%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

CNY 0.13

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.20x

Current Ratio

1.88x

Quick Ratio

1.52x

Div Yield

2.25%

Div Rate

CNY 0.17

Div Growth 1Y

+13.33%

Financials snapshotView financials →

Revenue (TTM)

2.29B

Net Income (TTM)

233.71M

Op. CF (TTM)

397.87M

Next earningsOct 23, 2026 →

Latest newsMore news →

Kangdelai announced its H1 2026 results: revenue of 1.089 billion yuan, down 3.21% year-on-year; net profit attributable to shareholders of 112 million yuan, down 10.23% year-on-year.10d ago

Similar companies

维力医疗603309.SH OrbusNeich Medical Group Holdings Limited06929.HK Warby Parker Inc.WRBY 奥泰生物688606.SH 拱东医疗605369.SH Pulse Biosciences, Inc.PLSE Find similar companies →

Latest newsMore news →

Kangdelai announced its H1 2026 results: revenue of 1.089 billion yuan, down 3.21% year-on-year; net profit attributable to shareholders of 112 million yuan, down 10.23% year-on-year.10d ago